According to reinsurer Sun Life the most costly conditions from a stop-loss insurance perspective are cancer generally, leukemia, ESRD, congenital anomalies and early births, transplants and congestive heart failure.
Evolent, which sells tools to help providers do value-based reimbursement and population health management and even start their own health plans, is paying $145 million for Valence Health, which does similar work. At least Evolent is using its over-valued stock for the deal and some cash.
Research in the Journal of the American Informatics Association finds that paper physician progress notes for hospitalized patients are more accurate than those in EHRs, but less comprehensive. The overall rate of accuracy is an astoundingly low 55%.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.